
Elizabeth Plimack MD
@ERPlimackMD
Followers
7K
Following
19K
Media
407
Statuses
4K
Deputy Director @FoxChaseCancer. Professor GU Med Onc. @ASCO BOD 2020-24. Views mine. COI: https://t.co/fmmRpMCIWd
Fox Chase Cancer Center
Joined May 2014
Comparison of Adjuvant regimens for cancer across tumor types #GU25. Nivolumab per Checkmate 274 for #bladdercancer rises to the top.
4
32
78
RT @KidneyCancer: 🚨 Applications are OPEN!. KCA is investing in the next generation of #KidneyCancer leaders through TWO unique mentorship….
0
5
0
RT @KidneyCancer: One month left to register for KCA's Women in RCC summer webinar! Join a conversation with @KimrynRathmell @OSUCCC_James….
0
3
0
RT @urotoday: EV-302 data: High CR rates and long-term survival with EV-pembro. @shilpaonc @ClevelandClinic joins @ERPlimackMD @FoxChaseCan….
0
1
0
RT @GUconference: Can ctDNA help us better define MRD in bladder cancer? Dr. @ERPlimackMD will explore this evolving space at #WorldGU25 in….
0
2
0
RT @FoxChaseCancer: @ERPlimackMD is joined by Andrea Necchi to discuss the SURE-02 trial, evaluating sacituzumab govitecan plus pembrolizum….
www.urotoday.com
Elizabeth Plimack is joined by Andrea Necchi to discuss the SURE-02 trial, evaluating sacituzumab govitecan plus pembrolizumab in a bladder-sparing approach for muscle-invasive bladder cancer....
0
1
0
RT @KidneyCancer: 🎉 We're so excited to have @KimrynRathmell @OSUCCC_James join us in conversation during the KCA's Women in RCC summer web….
0
7
0
RT @shilpaonc: #ASCO25 Was humbled to see a patient approach me on the heels of our presentation yesterday & sharing his experience of achi….
0
10
0
RT @shilpaonc: We are excited that @DemitriDedousis will soon be joining us as faculty in GU Onc & Genetics @CleClinicMD after an excellent….
0
8
0
RT @apolo_andrea: Very proud of our own @SaadAtiq24 @theNCI senior fellow presenting data on the Prevalence of Histology-Agnostic Biomarker….
0
27
0
RT @TiansterZhang: Great poster session this morning with @nsayeghmd highlighting work in #prostatecancer TMB & MSI-H w/ real world IO outc….
0
12
0
RT @TiansterZhang: A truly beautiful, patient centered discussion from Dr. #JackieBrown breaking the platinum ceiling in #bladdercancer - f….
0
9
0
RT @shilpaonc: Honored to be part of an incredible #GU oral session on bladder cancer #ASCO25. @CleClinicMD .With progress come new questi….
0
5
0
RT @drenriquegrande: EV-P is the right treatment. It’s time to learn how to really use it. #JacquelineBrown said. Wonderful discussion of n….
0
27
0
RT @KidneyCancer: Congrats @TiansterZhang on sharing the the latest #PDIGREE info at #ASCO25! Fascinating content - more on that soon - but….
0
13
0
Proud of our @FoxChaseCancer fellow #JoeVanGalen on his @ConquerCancerFd #ASCO25 YIA investigating novel approaches to irAE mgmt under the expert mentorship and guidance of @MattZibelman Thank you 🙏 to all CCF donors who make these awards possible #FoxChaseProud
0
9
20
RT @TiansterZhang: Join in for the opening session @ASCO #ASCO25 - @CliffordHudis tackling the current funding climate, ensuring @ConquerCa….
0
10
0
Devastating cut to @theNCI budget - sad to see US cancer research de-prioritized in this time of tremendous potential and innovation #ASCO25.
.@CliffordHudis at #ASCO25: ~40% cut to NCI budget in Admin's '26 proposal. We are in a tragic paradox: remarkable science & historic cuts to resources needed to turn these opps into hope for millions of pts. Our advocacy, is more important than ever➡️
0
7
12
RT @ASCO: .@CliffordHudis at #ASCO25: ~40% cut to NCI budget in Admin's '26 proposal. We are in a tragic paradox: remarkable science & hist….
asco.quorum.us
As Congress negotiates Fiscal Year 2025 appropriations bills, urge them to make cancer research a top priority.
0
29
0